Sanaria Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Rockville MD United States (2003)

Organization Overview

First Clinical Trial
2009
NCT01001650
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Sanaria Inc. | Sanaria Incorporated

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 1)

Infections (Phase 1)

Malaria (Phase 2)

Malaria, Falciparum (Phase 2)

Parasitemia (Phase 1)

Parasitic Diseases (Phase 1)

Protozoan Infections (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 31
  • # of Trial APIs: 18